A Comparison of Continuation Rates for Three Hormonal Contraceptive Methods
NCT00253019 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 321
Last updated 2013-08-21
Summary
This study will assess the continuation rates among women using oral contraceptive pills, Depo-Provera and Ortho Evra following a first trimester abortion.
Conditions
- Contraception
Sponsors & Collaborators
-
Emory University
lead OTHER
Principal Investigators
-
Carrie Cwiak, MD, MPH · Emory University
Eligibility
- Min Age
- 13 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2004-10-31
- Primary Completion
- 2005-11-30
- Completion
- 2005-11-30
Countries
- United States
Study Locations
More Related Trials
-
An Open-Label Study to Compare the Bleeding Profile of Norelgestromin/Ethinyl Estradiol in an Extended Regimen to Norelgestromin/Ethinyl Estradiol Given in a Traditional Regimen
NCT00320580 ·Status: COMPLETED ·Phase: PHASE2
-
Trial of Immediate Versus Delayed Initiation of Oral Contraceptive Pills After Abortion
NCT00235534 ·Status: COMPLETED ·Phase: NA
-
Hormonal Management of Heavy Menstrual Bleeding in Adolescents
NCT06740929 ·Status: RECRUITING
-
Ovarian Function and Reserve Parameters After Discontinuation of Long-term Use of Oral Contraception
NCT02785809 ·Status: UNKNOWN
-
A Research Study Looking Into the Effect of NNC0519-0130 on Blood Levels of a Birth Control Pill and Emptying of the Stomach in Women After Menopause
NCT06513104 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy, Safety, and Acceptability of Mifepristone 50 mg Once-weekly as a Contraceptive
NCT06394999 ·Status: RECRUITING ·Phase: PHASE3
-
A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy Women
NCT01252186 ·Status: COMPLETED ·Phase: PHASE2
-
To Compare SH T00658ID Over Ortho Tri-Cyclen Lo (US/Canada)
NCT00754065 ·Status: COMPLETED ·Phase: PHASE3
-
Metabolism of 0.35mg Norethindrone vs 5mg Norethindrone Acetate
NCT05294341 ·Status: COMPLETED ·Phase: PHASE4
-
Postpartum Etonogestrel Implant for Adolescents
NCT01666912 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Oral vs. Non-oral Contraceptives on the GH/IGF-1 Axis
NCT02367833 ·Status: COMPLETED ·Phase: PHASE4
-
Longitudinal Hemostatic Profile After Stopping Estroprogestative Contraceptives
NCT03949985 ·Status: COMPLETED
-
Depot Medroxyprogesterone Acetate as Emergency Contraception
NCT03395756 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Study of Safety and Efficacy of an Oral Contraceptive
NCT00391807 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Hormone Exposure From Multiple Commercial Lots of ORTHO EVRA (a Transdermal Contraceptive Patch)
NCT00258076 ·Status: COMPLETED ·Phase: PHASE1
-
Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception
NCT02021097 ·Status: UNKNOWN ·Phase: PHASE3
-
Oral Contraceptive Pills Versus Levonorgestrel-Releasing Intrauterine System for Niche-Related Abnormal Uterine Bleeding
NCT07229209 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate Cycle Control With Norgestimate/Ethinyl Estradiol and Drospirenone/Ethinyl Estradiol in Healthy Sexually Active Females
NCT00745901 ·Status: COMPLETED ·Phase: PHASE4
-
Research Study to Investigate the Effect of NNC0174-0833 on a Birth Control Pill in Women Who Are Not Able to Become Pregnant
NCT04074174 ·Status: COMPLETED ·Phase: PHASE1
-
Stopping Heavy Periods Project
NCT02002260 ·Status: UNKNOWN ·Phase: NA
-
Long-Acting Reversible Contraception
NCT01299116 ·Status: COMPLETED ·Phase: PHASE4
-
Comparative Trial in Hormone Withdrawal Associated Symptoms
NCT01076582 ·Status: COMPLETED ·Phase: PHASE3
-
Study of a Levonorgestrel 52 mg Intrauterine System for the Treatment of Heavy Menstrual Bleeding
NCT03642210 ·Status: COMPLETED ·Phase: PHASE3
-
Assessing Use Of Mifepristone After Progestin Priming For Use As "Missed Period Pills"
NCT04676776 ·Status: UNKNOWN ·Phase: PHASE2
-
Immediate Versus Delayed Initiation of Intrauterine System
NCT03708809 ·Status: WITHDRAWN ·Phase: NA